Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency

OBJECTIVE: On the basis of our previous work with triheptanoin, which provides key substrates to the Krebs cycle in the brain, we wished to assess its therapeutic effect in patients with glucose transporter type 1 deficiency syndrome (GLUT1-DS) who objected to or did not tolerate ketogenic diets. ME...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Neurol Neurosurg Psychiatry
Päätekijät: Mochel, Fanny, Hainque, Elodie, Gras, Domitille, Adanyeguh, Isaac M, Caillet, Samantha, Héron, Bénédicte, Roubertie, Agathe, Kaphan, Elsa, Valabregue, Romain, Rinaldi, Daisy, Vuillaumier, Sandrine, Schiffmann, Raphael, Ottolenghi, Chris, Hogrel, Jean-Yves, Servais, Laurent, Roze, Emmanuel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2016
Aiheet:
Movement Disorders
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4853553/
https://ncbi.nlm.nih.gov/pubmed/26536893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2015-311475
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia